IPPRA / Grant Monitor

2026-07-07
← Board

Metastasis Research Network (U54 Clinical Trial Not Allowed)

RFA-CA-27-012 · National Institutes of Health

biomedical clinical ai data science public health Health

Closes
2026-09-25 · 80 d
Award ceiling
$1,300,000
Award floor
Program funding
$6,800,000
Expected awards
4
Cost sharing
No
Posted
2026-06-04
Instrument
Cooperative Agreement
Characterization · gpt-5.4-mini · 2026-07-07

NCI will fund U54 specialized centers that conduct multidisciplinary basic research projects to advance systems-level understanding of cancer metastasis, including mechanisms such as early dissemination, microenvironment crosstalk, dormancy, and therapy response.

Funds
basic research
University
direct
physical sciences
minor
engineering
minor
life biomedical
central
computational data
substantial

⚑ Cooperative Agreement (U54) · Clinical trials not allowed · Foreign organizations and foreign components are allowed · MetNet center hub with 2-3 inter/multidisciplinary basic research projects

Unit fits — one characterization, each unit's own rules

Physical Sciences & Engineering (demo) 80 strong technical depth: substantial; funds basic research
IPPRA 45 partial peripheral portfolio topic: public_health; social/behavioral work is none; funds basic research; biomedical core — IPPRA health lane is communication/crisis/policy (capped); capped at 45 (limited social-science role)
Tom Love Innovation Hub 15 none deep-tech content; no commercialization signal

Description

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on developing a comprehensive and cohesive understanding of cancer metastasis. Towards this goal, the NCI will support U54 Specialized Centers that together will continue to serve as the hub of the Metastasis Research Network (MetNet). Each MetNet Center should propose an overarching scientific theme that will be pursued through two or three scientific inter- and multidisciplinary basic research projects. The projects should use integrative system level approaches to elucidate and integrate a mechanistic understanding of the non-linear, dynamic, and emergent processes in metastasis. Overarching themes should encompass the interplay between at least two central elements in the metastatic process such as early dissemination, cellular, soluble and/or physical microenvironment crosstalk, dormancy, or mechanisms of responses by metastatic cells to therapies. Studies on all types of cancer are welcome, including rare and pediatric metastatic cancers.Research proposed by MetNet Centers is expected to advance our understanding towards a more comprehensive appreciation of metastasis as a whole body, systems-level problem.

Eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Apply

View on Grants.gov → CONTACT: National Institutes of Health <NCIMetNet@mail.nih.gov>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · National Institutes of Health conventions SEE AN NIH EXAMPLE →

Funder-faithful document skeletons — National Institutes of Health's document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING